Evaxion A/S
EVAX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001828253
No open-market purchases or sales by Evaxion A/S insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $4.93M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Evaxion A/S changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 8 | 15 | +7 |
| Shares | 1.33M | 1.43M | +97.7K (+7.3%) |
| Value | $5.00M | $6.81M | +$1.81M (+36.2%) |
New holders (7)
Institutions that held Evaxion A/S at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Point72 Asset Management, L.P. | 33,100 | $157.9K | 0.00% |
| Stonepine Capital Management, LLC | 20,000 | $95.4K | 0.08% |
| SmartHarvest Portfolios, LLC | 15,194 | $72.5K | 0.03% |
| Wesbanco Bank Inc | 10,000 | $47.7K | 0.00% |
| Northwestern Mutual Wealth Management Co | 8,000 | $38.2K | 0.00% |
| Royal Bank of Canada | 3,900 | $19.0K | 0.00% |
| EverSource Wealth Advisors, LLC | 2,707 | $12.9K | 0.00% |
Sold out (0)
Institutions that held Evaxion A/S at the end of Q3 2025 and filed for Q4 2025 without it.
None.